Sign up to save your podcasts
Or
Share Inside Solid Tumor Therapies with BlueSphere Bio’s CEO Dr. David Apelian
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Inside Solid Tumor Therapies with BlueSphere Bio’s CEO Dr. David Apelian
We love to hear from our listeners. Send us a message.
BlueSphere Bio's CEO Dr. David Apelian explains the difficulties associated with treating solid tumor cancers as well as what the CGT sector needs to get right in the short term and why.
Subscribe to the podcast!
Apple | Spotify | YouTube
Visit my website: Cell & Gene
Connect with me on LinkedIn
View all episodes
By Erin Harris
4.9
3838 ratings
We love to hear from our listeners. Send us a message.
BlueSphere Bio's CEO Dr. David Apelian explains the difficulties associated with treating solid tumor cancers as well as what the CGT sector needs to get right in the short term and why.
Subscribe to the podcast!
Apple | Spotify | YouTube
Visit my website: Cell & Gene
Connect with me on LinkedIn
More shows like Cell & Gene: The Podcast
View all
Fareed Zakaria GPS
3,447 Listeners
Nature Podcast
756 Listeners
HBR IdeaCast
154 Listeners
Science Magazine Podcast
818 Listeners
The Daily
113,121 Listeners
Today, Explained
10,331 Listeners
The Readout Loud
337 Listeners
Short Wave
6,592 Listeners
The Prof G Pod with Scott Galloway
5,610 Listeners
Consider This from NPR
6,462 Listeners
Business Of Biotech
85 Listeners
Hard Fork
5,576 Listeners
The Weekly Show with Jon Stewart
11,013 Listeners
ASGCT Podcast Network
16 Listeners
Prof G Markets
1,480 Listeners